It's Going to Be a Big Year for These Pharma Companies

(Bloomberg) -- Goldman Sachs Group Inc. sees 2019 as “the year of NASH,” with late stage study results expected from the likes of Intercept Pharmaceuticals Inc., Gilead Sciences Inc., Allergan Plc ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.